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The presence of proline at the 249 aa position of the NS3 
gene is a mutation related to increased viremia potential 
and virus transmission rates in corvids (8).
In a recent study, Jiménez de Oya et al. performed 
experimental infection of Eurasian magpies with 2 WNV 
strains currently circulating in Europe; they found magpies 
to be highly susceptible to WNV infection, with low sur-
vival rates for both strains (9). No WNV-associated bird 
death had been reported in Greece previously, which could 
be attributed to the lack of an organized wild bird surveil-
lance system in the country. Nevertheless, mass deaths of 
Eurasian magpies showing neurologic signs, 1 month ear-
lier than a human neuroinvasive outbreak in the area, dem-
onstrate that monitoring sick birds (e.g., using oral swabs 
or feather pulp) or carcasses of dead wild birds, in an ac-
tive and passive surveillance system, could benefit public 
health by recognizing areas in which prevention measures 
could be implemented to minimize the impact of WNV hu-
man disease outbreaks.
The study was funded by the Prefecture of Peloponnese  
(Peloponissos A.E.), in the context of project “Monitoring the 
levels of infectious agents’ circulation and investigating the 
effect of environmental-hydrological parameters on vectors 
breeding sites.”
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In Russia, 131,590 cases of hemorrhagic fever with renal 
syndrome caused by 6 different hantaviruses were reported 
during 2000–2017. Most cases, 98.4%, were reported in 
western Russia. The average case-fatality rate was 0.4%, 
and strong regional differences were seen, depending on 
the predominant virus type.
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Hemorrhagic fever with renal syndrome (HFRS) is caused by hantaviruses (order Bunyavirales, family 
Hantaviridae), enveloped, single-strand, negative-sense 
RNA viruses, predominantly carried by rodents and insec-
tivores. In Asia, the primary HFRS pathogens are Hanta-
an virus (HTNV), Amur virus (AMRV), and Seoul virus 
(SEOV); in Europe, the primary pathogens are Puumala 
virus (PUUV) and Dobrava-Belgrade virus (DOBV) (1). 
Russia, bordered by Europe in the west and Asia in the 
east, included HFRS in the official reporting system of the 
Ministry of Public Health in 1978 (2). Clinical and labora-
tory diagnoses for reported cases are confirmed serologi-
cally by indirect immunofluorescence assay (Diagnostikum 
HFRS; Federal Scientific Center for Research and Devel-
opment of Immune and Biological Products of the Russian 
Academy of Sciences, http://chumakovs.ru). 
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Figure. Distribution of hemorrhagic fever with renal syndrome caused by hantavirus in Russia, 2000–2017. A) Mean number of reported 
cases and incidence of disease, by region; B) geographic distribution and incidence rate of causative agents (indicated by numbers). 
Red stars indicate primary cities in Russia.
HFRS has the highest incidence rate of all reportable 
zoonotic viral diseases in Russia. In the west, in administra-
tive regions close to the border with Europe, reported cases 
mainly are caused by PUUV carried by bank voles (Myo-
des glareolus) and to a lesser extent by 2 types of DOBV, 
Kurkino virus (KURV) and Sochi virus (SOCV) (3). Vec-
tors for DOBV subtypes in western Russia are the western 
subtype of striped field mouse (Apodemus agrarius agrar-
ius), which hosts KURV, in the central regions; and the 
Black Sea field mouse (A. ponticus), which hosts SOCV, 
in southern regions. In eastern Russia, near the border with 
Asia, HFRS cases primarily are caused by HTNV carried 
by the eastern subtype of striped field mouse (A. agrarius 
mantchuricus), AMRV carried by the Korean field mouse 
(A. peninsulae), and, less frequently, SEOV carried by the 
Norway rat (Rattus norvegicus) (4,5).
During 2000–2017, a total of 68 of Russia’s 85 admin-
istrative regions reported 131,590 HFRS cases, an annual 
average rate of 4.9 cases/100,000 inhabitants (Figure 1, 
panel A). Annual incidence rates varied greatly, and epi-
demics occurred every 2–4 years with occasional 2-year 
peaks, such as in 2008–2009 and 2014–2015. This phenom-
enon is related to sequential independent epidemic years in 
2 distinct, highly affected regions rather than geographical-
ly synchronized hantavirus activity on a nationwide scale.
HFRS cases were distributed unevenly throughout 
Russia. Western Russia reported 129,530 (98.4%) cases 
in 52/60 regions and an average annual incidence of 6.0 
cases/100,000 persons. Eastern Russia reported only 2,060 
(1.6%) cases in 16/25 regions and an average annual in-
cidence of 0.4 cases/100,000 persons (2). The Ural and 
Ural-Volga-Viatka foothill areas, which encompass 11 
administrative regions of western Russia, had the highest 
HFRS incidence rates, >10 cases/100,000 persons (Figure 
1, panel B). Overall, 77% of HFRS cases in Russia were 
reported from these 11 regions, which are characterized 
by lime forests that provide suitable habitat for the bank 
vole, the reservoir host of PUUV. Among these regions, 2 
had the highest incidence rates in the country: Udmurtia 
had 61.4 cases/100,000 persons and Bashkiria 47.5 cas-
es/100,000 persons.
In eastern Russia, the 4 administrative regions closest 
to Asia reported HFRS cases. Vladivostok reported 1,089 
cases and an incidence rate of 3.0 cases/100,000 persons; 
Khabarovsk reported 519 cases and an incidence rate of 
2.1 cases/100,000 persons; Amur reported 71 cases and an 
incidence rate of 0.4 cases/100,000 persons; and Jewish 
Autonomous Region reported 189 cases and an incidence 
rate of 5.8 cases/100,000 persons. Siberia reported only 
179 cases, mainly from western Siberia, which likely were 
imported cases in temporary oil and gas field workers from 
other hantavirus-endemic regions, such as the neighboring 
Udmurtia and Bashkiria.
During 2000–2017, Russia had 564 fatal cases of 
HFRS, 483 in the east and 81 in the west. The overall case-
fatality rate was 0.4%, but rates varied by region. Central 
regions of western Russia had case-fatality rates of 0.3%, 
but the Black Sea coastal area of western Russia, where 
highly pathogenic SOCV occurs, had a 14% HFRS case-
fatality rate. The far eastern regions, which have endemic 
highly pathogenic HTNV, had a 7% case-fatality rate (6–9).
HFRS appears to affect persons 20–50 years of age 
most frequently (65%), and ≈80% of cases in Russia were 
in men. Only 3,157 (2.4%) cases were reported among chil-
dren <14 years of age. Most HFRS cases in western Rus-
sia occurred during the summer and autumn, but cases in 
the far eastern part of the country occurred in autumn and 
winter (4,5).
Comparative analyses of clinical courses indicated that 
even though infections by all recognized causative agents 
can cause mild, moderate, and severe clinical forms of 
HFRS, the frequency differs depending on the causative 
agent. SOCV infections had greater incidence of severe 
HRFS and high case-fatality rates (14%) and HTNV infec-
tions had case-fatality rates of 5%–8%, whereas PUUV, 
SEOV, and KURV infections had case-fatality rates <1% 
(8–10). Of note, 97.7% of HFRS cases in Russia are report-
edly caused by PUUV (5), possibly explaining the overall 
low case-fatality rate in the country. Nevertheless, consid-
ering the high case numbers reported from the west, HFRS 
remains a public health threat in Russia.
This study was supported by Russian Academic Excellence 
Project 5-100.
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A 17-month-old boy in India with severe acute respiratory 
infection was laboratory confirmed to have avian influenza 
A(H9N2) virus infection. Complete genome analysis of the 
strain indicated a mixed lineage of G1 and H7N3. The strain 
also was found to be susceptible to adamantanes and neur-
aminidase inhibitors.
Low-pathogenicity avian influenza A(H9N2) viruses have a wide host range, and outbreaks in poultry 
have been recorded since the 1990s in China (1). In In-
dia, avian specimens indicated no serologic evidence of 
H5N1 and H9N2 during 1958–1981 (2); however, 5%–
6% persons with direct exposure to poultry had H9N2 
antibodies (3). Human cases of influenza H9N2 virus in-
fection have been observed in Hong Kong, China, Ban-
gladesh, and Pakistan (4–7).
An institutional review board approved an ongoing 
community-based surveillance in 93 villages of Korku 
tribes in Melghat District, Maharashtra State, India, to de-
termine incidence of respiratory syncytial virus (RSV)–as-
sociated deaths among children <2 years of age. A total of 
2,085 nasopharyngeal swabs from children with severe or 
fatal pneumonia were transported to India’s National Insti-
tute of Virology to test for influenza, RSV, and other respi-
ratory viruses. A nasopharyngeal swab from a 17-month-
old boy received on February 12, 2019, tested positive by 
PCR for influenza A(H9N2) virus.
The child, a resident of Melghat, had fever, cough, 
breathlessness, and difficulty feeding for 2 days after 
illness onset on January 31, 2019. His high intermittent 
grade fever had no diurnal variation and no association 
with rash or mucocutaneous lesions. Examination re-
vealed a conscious, restless child with a respiratory rate 
of 48 breaths/min and lower chest wall in-drawing with 
intermittent absence of breathing for >20 seconds. He 
was fully immunized for his age, with bacillus Calmette–
Guérin, diphtheria, hepatitis B, poliovirus, and measles 
vaccines. Both length and weight for age were less than 
–3 SD. History of travel with his parents to a local reli-
gious gathering 1 week before symptom onset was elic-
ited. The father had similar symptoms on return from the 
gathering but could not undergo serologic testing because 
of his migrant work. No history of poultry exposure was 
elicited. The child received an antibacterial drug and anti-
pyretics and recovered uneventfully.
We tested the clinical sample using duplex real-time 
PCR for influenza A/B, H3N2, and 2009 pandemic H1N1 
viruses; RSV A/B; human metapneumovirus; parainfluenza 
virus types 1–4; rhinovirus; and adenovirus. The sample 
was strongly positive for influenza A virus (cycle thresh-
old value 20) but negative for seasonal influenza viruses 
and all respiratory viruses. Real-time PCR analysis for 
avian influenza viruses H5N1, H7N9, H10N8, and H9N2 
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